Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2019 19:30 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces New Leadership Appointment and Board Change

TORONTO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive" and the “Company") (CSE: RVV), a cannabis life sciences company focused on the research, development, and...
November 27, 2019 18:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Results for the Three Months Ended September 30, 2019

TORONTO, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and...
November 14, 2019 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Joint Venture with Herman Holdings for the Production of Cannabis Derivative Products in Canada

TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and...
November 12, 2019 08:25 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Non-Binding Letter of Intent to Acquire Greeninsightz Limited and Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. TORONTO, Nov. 12, 2019 (GLOBE...
October 24, 2019 17:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2019

TORONTO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive") (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and commercialization of...
October 17, 2019 17:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics and Herman Holdings Enter Into Non-Binding Letter of Intent to Merge

TORONTO, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive") (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and commercialization of...
July 19, 2019 10:03 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Approval of CSE Listing and Delisting from TSX-V

TORONTO, July 19, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development,...
June 20, 2019 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Cannabis Product Derivative Manufacturing and Development Facility

TORONTO, June 20, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development,...
May 30, 2019 18:30 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2019

TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) ("Revive" or the “Company”), a specialty cannabis company focused on the research,...
April 17, 2019 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces United States Patent Grant for Cannabinoid Delivery System

TORONTO, April 17, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development...